IL-2 Market Projected to Hit USD 4 Billion by 2034, Fueled by Fusion Proteins, Monoclonal Antibodies, and Gene Therapies Across Immunology, Dermatology, Neurodegenerative Diseases, and Oncology | DelveInsight | #interleukin-2 # Interleukin-2 Clinical Trials # Interleukin-2 Companies # Interleukin-2 Drugs